Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDivis laboratories

    Divis Laboratories

    Jump to

    • Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey

      Deven Choksey recommended Accumulate rating on Divis Laboratories with a target price of Rs 6795 in its research report dated November 20, 2025.

    • Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y

    • Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Divis Laboratories with a target price of Rs 6925 in its research report dated November 08, 2025.

    • Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y

    • Accumulate Divis Laboratories; target of Rs 7050: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Divis Laboratories with a target price of Rs 7050 in its research report dated November 10, 2025.

    • Sell Divis Laboratories; target of Rs 5400: ICICI Securities

      ICICI Securities is bearish on Divis Laboratories has recommended sell rating on the stock with a target price of Rs 5400 in its research report dated November 09, 2025.

    • Reduce Divis Laboratories; target of Rs 5400: Geojit Financial Services

      Geojit Financial Services recommended reduce rating on Divis Laboratories with a target price of Rs 5400 in its research report dated September 10, 2025.

    • Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Divis Laboratories with a target price of Rs 6550 in its research report dated August 07, 2025.

    • Divis Labs Standalone June 2025 Net Sales at Rs 2,357.00 crore, up 14.25% Y-o-Y

    • Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey

      Deven Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 7518 in its research report dated May 23, 2025.

    • Reduce Divi's Laboratories: target of Rs 5,610: ICICI Securities

      ICICI Securities recommended reduce rating on Divi's Laboratories with a target price of Rs 5,610 in its research report dated May 19, 2025.

    • Trade Spotlight: How should you trade Tejas Networks, JSW Energy, APL Apollo, Divis Labs, Supreme Industries, Nippon Life, GE Vernova and others on May 20?

      The market is likely to consolidate further and may attempt to surpass last Thursday's swing high. Below are some short-term trading ideas to consider.

    • Divis Labs Consolidated March 2025 Net Sales at Rs 2,585.00 crore, up 12.24% Y-o-Y

    • Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?

      Divi's Labs reported a 23 percent jump in net profit for the three months ended March at Rs 662 crore.

    • Divis Labs Standalone March 2025 Net Sales at Rs 2,536.00 crore, up 12.26% Y-o-Y

    • Stocks to Watch Today: Divis Labs, Premier Energies, Delhivery, Dr Reddys, Bharat Electronics, KEC International, Sun Pharma, PNC Infratech in focus on 19 May

      Stocks to Watch, 19 May: Stocks like Zen Technologies, Arvind Fashions, Galaxy Surfactants, KRBL, Kalpataru Projects International, IOL Chemicals, Repco Home Finance, CreditAccess Grameen, Dhampur Sugar Mills, Gujarat Alkalies, Kaynes Technology India, Texmaco Rail & Engineering, Sterlite Technologies, and Dr Reddy's Laboratories will be in focus on May 19.

    • Trade Spotlight: How should you trade Divis Labs, APL Apollo Tubes, UPL, GMR Airports, Jubilant Pharmova, Ceat and others on April 25?

      The key indices are likely to consolidate and remain range-bound in the upcoming sessions. Below are some trading ideas for the near term.

    • Trade Spotlight: How should you trade Kotak Mahindra Bank, Zomato, UPL, BSE, Ashok Leyland, and others on February 20?

      The market is expected to gain strength soon amid ongoing range-bound trading. Below are some trading ideas for the near term.

    • Neutral Divis Laboratories; target of Rs 6200: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Divis Laboratories with a target price of Rs 6200 in its research report dated February 03, 2025.

    • Accumulate Divis Laboratories; target of Rs 6435: KR Choksey

      KR Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 6435 in its research report dated February 05 2025.

    • Accumulate Divis Laboratories; target of Rs 6250 Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Divis Laboratories with a target price of Rs 6250 in its research report dated February 04, 2024.

    • Divi's Labs shares soar 5% as investors cheer solid Q3 earnings

      Divi's Labs delivered well rounded earnings growth in Q3, beating expectations on all major parameters--profit, revenue and profitability.

    • Divis Labs Consolidated December 2024 Net Sales at Rs 2,319.00 crore, up 25.01% Y-o-Y

    • Divis Labs Standalone December 2024 Net Sales at Rs 2,297.00 crore, up 27.05% Y-o-Y

    • Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21?

      The market may extend its upward journey, but sustainability is the key to watch, given the elevated volatility. Below are some trading ideas for the near term.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347